Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets

Wang, N.; Zhan, Y.; Zhu, L.; Hou, Z.; Liu, F.; Song, P.; Qiu, F.; Wang, X.; Zou, X.; Wan, D.; Qian, X.; Wang, S.; Guo, Y.; Yu, H.; Cui, M.; Tong, G.; Xu, Y.; Zheng, Z.; Lu, Y.; Hong, P. Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients. Cell Host Microbe, 2020, 28(3), 455-464.e2.
[http://dx.doi.org/10.1016/j.chom.2020.07.005] [PMID: 32707096]

Chan, J.F.W.; Yuan, S.; Kok, K.H.; To, K.K.W.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C.C.Y.; Poon, R.W.S.; Tsoi, H.W.; Lo, S.K.F.; Chan, K.H.; Poon, V.K.M.; Chan, W.M.; Ip, J.D.; Cai, J.P.; Cheng, V.C.C.; Chen, H.; Hui, C.K.M.; Yuen, K.Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 395(10223), 514-523.
[http://dx.doi.org/10.1016/S0140-6736(20)30154-9] [PMID: 31986261]

Wu, A.; Peng, Y.; Huang, B.; Ding, X.; Wang, X.; Niu, P.; Meng, J.; Zhu, Z.; Zhang, Z.; Wang, J.; Sheng, J.; Quan, L.; Xia, Z.; Tan, W.; Cheng, G.; Jiang, T. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in china. Cell Host Microbe, 2020, 27(3), 325-328.
[http://dx.doi.org/10.1016/j.chom.2020.02.001] [PMID: 32035028]

Wu, F.; Zhao, S.; Yu, B.; Chen, Y.M.; Wang, W.; Song, Z.G.; Hu, Y.; Tao, Z.W.; Tian, J.H.; Pei, Y.Y.; Yuan, M.L.; Zhang, Y.L.; Dai, F.H.; Liu, Y.; Wang, Q.M.; Zheng, J.J.; Xu, L.; Holmes, E.C.; Zhang, Y.Z. A new coronavirus associated with human respiratory disease in China. Nature, 2020, 579(7798), 265-269.
[http://dx.doi.org/10.1038/s41586-020-2008-3] [PMID: 32015508]

Israeli, E. Novel Coronavirus that recently emerged in China. Harefuah, 2020, 159(1), 70-71.
[PMID: 32048481]

Sumon, T.A.; Hussain, M.A.; Hasan, M.T.; Hasan, M.; Jang, W.J.; Bhuiya, E.H.; Chowdhury, A.A.M.; Sharifuzzaman, S.M.; Brown, C.L.; Kwon, H.J.; Lee, E.W. A Revisit to the research updates of drugs, vaccines, and bioinformatics approaches in combating COVID-19 pandemic. Front. Mol. Biosci., 2021, 7, 585899.
[http://dx.doi.org/10.3389/fmolb.2020.585899] [PMID: 33569389]

Anand, K.; Ziebuhr, J.; Wadhwani, P.; Mesters, J.R.; Hilgenfeld, R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science, 2003, 300(5626), 1763-1767.
[http://dx.doi.org/10.1126/science.1085658] [PMID: 12746549]

V’kovski, P.; Kratzel, A.; Steiner, S.; Stalder, H.; Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol., 2021, 19(3), 155-170.
[http://dx.doi.org/10.1038/s41579-020-00468-6] [PMID: 33116300]

Li, G.; De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov., 2020, 19(3), 149-150.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]

Khandker, S.S.; Godman, B.; Jawad, M.I.; Meghla, B.A.; Tisha, T.A.; Khondoker, M.U.; Haq, M.A.; Charan, J.; Talukder, A.A.; Azmuda, N.; Sharmin, S.; Jamiruddin, M.R.; Haque, M.; Adnan, N. A systematic review on covid-19 vaccine strategies, their effectiveness, and issues. Vaccines (Basel), 2021, 9(12), 1387.
[http://dx.doi.org/10.3390/vaccines9121387] [PMID: 34960133]

Morales-Núñez, J.J.; Muñoz-Valle, J.F.; Meza-López, C.; Wang, L.F.; Machado Sulbarán, A.C.; Torres-Hernández, P.C.; Bedolla-Barajas, M.; De la O-Gómez, B.; Balcázar-Félix, P.; Hernández-Bello, J. Neutralizing antibodies titers and side effects in response to BNT162b2 vaccine in healthcare workers with and without prior SARS-CoV-2 infection. Vaccines (Basel), 2021, 9(7), 742.
[http://dx.doi.org/10.3390/vaccines9070742] [PMID: 34358158]

Davidson, A.M.; Wysocki, J.; Batlle, D. Interaction of SARS-CoV-2 and other coronavirus with ACE (Angiotensin-Converting Enzyme)-2 as their main receptor: Therapeutic implications. Hypertens., 2020, 76(5), 1339-1349.

Butler, C.C.; Yu, L.M.; Dorward, J.; Gbinigie, O.; Hayward, G.; Saville, B.R.; Van Hecke, O.; Berry, N.; Detry, M.A.; Saunders, C.; Fitzgerald, M.; Harris, V.; Djukanovic, R.; Gadola, S.; Kirkpatrick, J.; de Lusignan, S.; Ogburn, E.; Evans, P.H.; Thomas, N.P.B.; Patel, M.G.; Hobbs, F.D.R. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir. Med., 2021, 9(9), 1010-1020.
[http://dx.doi.org/10.1016/S2213-2600(21)00310-6] [PMID: 34329624]

Xia, Q.; Dai, W.; Xu, K.; Ni, Q.; Li, Y.; Liu, J.; Zhao, H.; Guo, Y.; Yu, L.; Yi, P.; Su, J.; Lang, G.; Tao, J.; Shi, D.; Wu, W.; Wu, X.; Xu, Y.; Xu, M.; Yu, L.; Wang, X.; Cai, H.; Fang, Q.; Zhou, J.; Qiu, Y.; Li, L. Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019. J. Med. Virol., 2021, 93(7), 4446-4453.
[http://dx.doi.org/10.1002/jmv.26798] [PMID: 33448426]

Pilkington, V.; Pepperrell, T.; Hill, A. A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic? J. Virus Erad., 2020, 6(2), 45-51.
[http://dx.doi.org/10.1016/S2055-6640(20)30016-9] [PMID: 32405421]

Saini, M.; Rana, M.; Bhatti, K.; Das, R.; Mehta, D.K.; Chidurala, R.M. Clinical efficacy of Remdesivir and Favipiravir in the treatment of Covid-19 patients: Scenario so far. Curr. Drug Res. Rev., 2021, 13.
[PMID: 34365935]

Senanayake, S.L. Drug repurposing strategies for COVID-19; Futur. Drug Discov, 2020.

Elfiky, A.A. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci., 2020, 253, 117592.
[http://dx.doi.org/10.1016/j.lfs.2020.117592] [PMID: 32222463]

Self, W.H.; Semler, M.W.; Leither, L.M.; Casey, J.D.; Angus, D.C.; Brower, R.G.; Chang, S.Y.; Collins, S.P.; Eppensteiner, J.C.; Filbin, M.R.; Files, D.C.; Gibbs, K.W.; Ginde, A.A.; Gong, M.N.; Harrell, F.E., Jr; Hayden, D.L.; Hough, C.L.; Johnson, N.J.; Khan, A.; Lindsell, C.J.; Matthay, M.A.; Moss, M.; Park, P.K.; Rice, T.W.; Robinson, B.R.H.; Schoenfeld, D.A.; Shapiro, N.I.; Steingrub, J.S.; Ulysse, C.A.; Weissman, A.; Yealy, D.M.; Thompson, B.T.; Brown, S.M.; Steingrub, J.; Smithline, H.; Tiru, B.; Tidswell, M.; Kozikowski, L.; Thornton-Thompson, S.; De Souza, L.; Hou, P.; Baron, R.; Massaro, A.; Aisiku, I.; Fredenburgh, L.; Seethala, R.; Johnsky, L.; Riker, R.; Seder, D.; May, T.; Baumann, M.; Eldridge, A.; Lord, C.; Shapiro, N.; Talmor, D.; O’Mara, T.; Kirk, C.; Harrison, K.; Kurt, L.; Schermerhorn, M.; Banner-Goodspeed, V.; Boyle, K.; Dubosh, N.; Filbin, M.; Hibbert, K.; Parry, B.; Lavin-Parsons, K.; Pulido, N.; Lilley, B.; Lodenstein, C.; Margolin, J.; Brait, K.; Jones, A.; Galbraith, J.; Peacock, R.; Nandi, U.; Wachs, T.; Matthay, M.; Liu, K.; Kangelaris, K.; Wang, R.; Calfee, C.; Yee, K.; Hendey, G.; Chang, S.; Lim, G.; Qadir, N.; Tam, A.; Beutler, R.; Levitt, J.; Wilson, J.; Rogers, A.; Vojnik, R.; Roque, J.; Albertson, T.; Chenoweth, J.; Adams, J.; Pearson, S.; Juarez, M.; Almasri, E.; Fayed, M.; Hughes, A.; Hillard, S.; Huebinger, R.; Wang, H.; Vidales, E.; Patel, B.; Ginde, A.; Moss, M.; Baduashvili, A.; McKeehan, J.; Finck, L.; Higgins, C.; Howell, M.; Douglas, I.; Haukoos, J.; Hiller, T.; Lyle, C.; Cupelo, A.; Caruso, E.; Camacho, C.; Gravitz, S.; Finigan, J.; Griesmer, C.; Park, P.; Hyzy, R.; Nelson, K.; McDonough, K.; Olbrich, N.; Williams, M.; Kapoor, R.; Nash, J.; Willig, M.; Ford, H.; Gardner-Gray, J.; Ramesh, M.; Moses, M.; Ng Gong, M.; Aboodi, M.; Asghar, A.; Amosu, O.; Torres, M.; Kaur, S.; Chen, J.T.; Hope, A.; Lopez, B.; Rosales, K.; Young You, J.; Mosier, J.; Hypes, C.; Natt, B.; Borg, B.; Salvagio Campbell, E.; Hite, R.D.; Hudock, K.; Cresie, A.; Alhasan, F.; Gomez-Arroyo, J.; Duggal, A.; Mehkri, O.; Hastings, A.; Sahoo, D.; Abi Fadel, F.; Gole, S.; Shaner, V.; Wimer, A.; Meli, Y.; King, A.; Terndrup, T.; Exline, M.; Pannu, S.; Robart, E.; Karow, S.; Hough, C.; Robinson, B.; Johnson, N.; Henning, D.; Campo, M.; Gundel, S.; Seghal, S.; Katsandres, S.; Dean, S.; Khan, A.; Krol, O.; Jouzestani, M.; Huynh, P.; Weissman, A.; Yealy, D.; Scholl, D.; Adams, P.; McVerry, B.; Huang, D.; Angus, D.; Schooler, J.; Moore, S.; Files, C.; Miller, C.; Gibbs, K.; LaRose, M.; Flores, L.; Koehler, L.; Morse, C.; Sanders, J.; Langford, C.; Nanney, K.; MdalaGausi, M.; Yeboah, P.; Morris, P.; Sturgill, J.; Seif, S.; Cassity, E.; Dhar, S.; de Wit, M.; Mason, J.; Goodwin, A.; Hall, G.; Grady, A.; Chamberlain, A.; Brown, S.; Bledsoe, J.; Leither, L.; Peltan, I.; Starr, N.; Fergus, M.; Aston, V.; Montgomery, Q.; Smith, R.; Merrill, M.; Brown, K.; Armbruster, B.; Harris, E.; Middleton, E.; Paine, R.; Johnson, S.; Barrios, M.; Eppensteiner, J.; Limkakeng, A.; McGowan, L.; Porter, T.; Bouffler, A.; Leahy, J.C.; deBoisblanc, B.; Lammi, M.; Happel, K.; Lauto, P.; Self, W.; Casey, J.; Semler, M.; Collins, S.; Harrell, F.; Lindsell, C.; Rice, T.; Stubblefield, W.; Gray, C.; Johnson, J.; Roth, M.; Hays, M.; Torr, D.; Zakaria, A.; Schoenfeld, D.; Thompson, T.; Hayden, D.; Ringwood, N.; Oldmixon, C.; Ulysse, C.; Morse, R.; Muzikansky, A.; Fitzgerald, L.; Whitaker, S.; Lagakos, A.; Brower, R.; Reineck, L.; Aggarwal, N.; Bienstock, K.; Freemer, M.; Maclawiw, M.; Weinmann, G.; Morrison, L.; Gillespie, M.; Kryscio, R.; Brodie, D.; Zareba, W.; Rompalo, A.; Boeckh, M.; Parsons, P.; Christie, J.; Hall, J.; Horton, N.; Zoloth, L.; Dickert, N.; Diercks, D. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: A randomized clinical trial. JAMA, 2020, 324(21), 2165-2176.
[http://dx.doi.org/10.1001/jama.2020.22240] [PMID: 33165621]

Geleris, J.; Sun, Y.; Platt, J.; Zucker, J.; Baldwin, M.; Hripcsak, G.; Labella, A.; Manson, D.K.; Kubin, C.; Barr, R.G.; Sobieszczyk, M.E.; Schluger, N.W. Observational study of Hydroxychloroquine in hospitalized patients with COVID-19. N. Engl. J. Med., 2020, 382(25), 2411-2418.
[http://dx.doi.org/10.1056/NEJMoa2012410] [PMID: 32379955]

Gordon, A.C.; Angus, D.C.; Derde, L.P.G. Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N. Engl. J. Med., 2021, 385(12), 1147-1149.
[http://dx.doi.org/10.1056/NEJMc2108482] [PMID: 34407335]

Li, L.; Zhang, W.; Hu, Y.; Tong, X.; Zheng, S.; Yang, J.; Kong, Y.; Ren, L.; Wei, Q.; Mei, H.; Hu, C.; Tao, C.; Yang, R.; Wang, J.; Yu, Y.; Guo, Y.; Wu, X.; Xu, Z.; Zeng, L.; Xiong, N.; Chen, L.; Wang, J.; Man, N.; Liu, Y.; Xu, H.; Deng, E.; Zhang, X.; Li, C.; Wang, C.; Su, S.; Zhang, L.; Wang, J.; Wu, Y.; Liu, Z. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: A randomized clinical trial. JAMA, 2020, 324(5), 460-470.
[http://dx.doi.org/10.1001/jama.2020.10044] [PMID: 32492084]

Salazar, E.; Perez, K.K.; Ashraf, M.; Chen, J.; Castillo, B.; Christensen, P.A.; Eubank, T.; Bernard, D.W.; Eagar, T.N.; Long, S.W.; Subedi, S.; Olsen, R.J.; Leveque, C.; Schwartz, M.R.; Dey, M.; Chavez-East, C.; Rogers, J.; Shehabeldin, A.; Joseph, D.; Williams, G.; Thomas, K.; Masud, F.; Talley, C.; Dlouhy, K.G.; Lopez, B.V.; Hampton, C.; Lavinder, J.; Gollihar, J.D.; Maranhao, A.C.; Ippolito, G.C.; Saavedra, M.O.; Cantu, C.C.; Yerramilli, P.; Pruitt, L.; Musser, J.M. Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma. Am. J. Pathol., 2020, 190(8), 1680-1690.
[http://dx.doi.org/10.1016/j.ajpath.2020.05.014] [PMID: 32473109]

Breining, P.; Frølund, A.L.; Højen, J.F.; Gunst, J.D.; Staerke, N.B.; Saedder, E.; Cases-Thomas, M.; Little, P.; Nielsen, L.P.; Søgaard, O.S.; Kjolby, M. Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety. Basic Clin. Pharmacol. Toxicol., 2021, 128(2), 204-212.
[http://dx.doi.org/10.1111/bcpt.13533] [PMID: 33176395]

Ledford, H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature, 2020, 582(7813), 469.
[http://dx.doi.org/10.1038/d41586-020-01824-5] [PMID: 32546811]

Uzunova, K.; Filipova, E.; Pavlova, V.; Vekov, T. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Biomed. Pharmacother., 2020, 131, 110668.
[http://dx.doi.org/10.1016/j.biopha.2020.110668] [PMID: 32861965]

Koul, S.; Pandurangan, A.; Khosa, R.L. Wedelia chinenis (Asteraceae) – An overview. Asian Pac. J. Trop. Biomed., 2012, 2(2)(Suppl.), S1169-S1175.
[http://dx.doi.org/10.1016/S2221-1691(12)60380-3]

Suwannarach, N.; Kumla, J.; Sujarit, K.; Pattananandecha, T.; Saenjum, C.; Lumyong, S. Natural bioactive compounds from fungi as potential candidates for protease inhibitors and immunomodulators to apply for coronaviruses. Molecules, 2020, 25(8), 1800.

Trott, O.; Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2010, 31(2), 455-461.
[PMID: 19499576]

Lipinski, C.A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today. Technol., 2004, 1(4), 337-341.
[http://dx.doi.org/10.1016/j.ddtec.2004.11.007] [PMID: 24981612]

Banerjee, P.; Eckert, A.O.; Schrey, A.K.; Preissner, R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res., 2018, 46(Web Server issue), W257.
[http://dx.doi.org/10.1093/nar/gky318]

Sen, D.; Debnath, P.; Debnath, B.; Bhaumik, S.; Debnath, S. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. J. Biomol. Struct. Dyn., 2022, 40(2), 941-962.
[http://dx.doi.org/10.1080/07391102.2020.1819883] [PMID: 32948116]

Hu, X.; Cai, X.; Song, X.; Li, C.; Zhao, J.; Luo, W.; Zhang, Q.; Ekumi, I.O.; He, Z. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol., 2020, 15(6), 359-368.
[http://dx.doi.org/10.2217/fvl-2020-0099]

Ibrahim, M.A.A.; Abdelrahman, A.H.M.; Hussien, T.A.; Badr, E.A.A.; Mohamed, T.A.; El-Seedi, H.R.; Pare, P.W.; Efferth, T.; Hegazy, M.E.F. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput. Biol. Med., 2020, 126, 104046.
[http://dx.doi.org/10.1016/j.compbiomed.2020.104046] [PMID: 33065388]

Ibrahim, M.A.A.; Mohamed, E.A.R.; Abdelrahman, A.H.M.; Allemailem, K.S.; Moustafa, M.F.; Shawky, A.M.; Mahzari, A.; Hakami, A.R.; Abdeljawaad, K.A.A.; Atia, M.A.M. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. J. Mol. Graph. Model., 2021, 105, 107904.
[http://dx.doi.org/10.1016/j.jmgm.2021.107904] [PMID: 33798836]

Singh, R.H.; Narsimhamurthy, K.; Singh, G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology, 2008, 9(6), 369-374.
[http://dx.doi.org/10.1007/s10522-008-9185-z] [PMID: 18931935]

Rawat, S.; Jugran, A.K.; Bhatt, I.D.; Rawal, R.S. Hedychium spicatum: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus. J. Pharm. Pharmacol., 2018, 70(6), 687-712.
[http://dx.doi.org/10.1111/jphp.12890] [PMID: 29484653]

Alam, P.; Tyagi, R.; Farah, M.A.; Rehman, M.T.; Hussain, A.; AlAjmi, M.F.; Siddiqui, N.A.; Al-Anazi, K.M.; Amin, S.; Mujeeb, M.; Mir, S.R. Cytotoxicity and molecular docking analysis of racemolactone I, a new sesquiterpene lactone isolated from Inula racemosa. Pharm. Biol., 2021, 59(1), 941-952.
[http://dx.doi.org/10.1080/13880209.2021.1946090] [PMID: 35294328]

Patel, J.J.; Acharya, S.R.; Acharya, N.S. Clerodendrum serratum (L.) Moon. – A review on traditional uses, phytochemistry and pharmacological activities. J. Ethnopharmacol., 2014, 154(2), 268-285.
[http://dx.doi.org/10.1016/j.jep.2014.03.071] [PMID: 24727551]

Mwangi, R.W.; Macharia, J.M.; Wagara, I.N.; Bence, R.L. The medicinal properties of Cassia fistula L: A review. Biomed. Pharmacother., 2021, 144, 112240.
[http://dx.doi.org/10.1016/j.biopha.2021.112240] [PMID: 34601194]

Logesh, R.; Das, N.; Adhikari-Devkota, A.; Devkota, H.P. Cocculus hirsutus (L.) W.Theob. (Menispermaceae): A Review on traditional uses, phytochemistry and pharmacological activities. Medicines (Basel), 2020, 7(11), 69.
[http://dx.doi.org/10.3390/medicines7110069] [PMID: 33182572]

Yin, W.; Mao, C.; Luan, X.; Shen, D.D.; Shen, Q.; Su, H.; Wang, X.; Zhou, F.; Zhao, W.; Gao, M.; Chang, S.; Xie, Y.C.; Tian, G.; Jiang, H.W.; Tao, S.C.; Shen, J.; Jiang, Y.; Jiang, H.; Xu, Y.; Zhang, S.; Zhang, Y.; Xu, H.E. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science, 2020, 368(6498), 1499-1504.
[http://dx.doi.org/10.1126/science.abc1560] [PMID: 32358203]

Wang, Q.; Zhang, Y.; Wu, L.; Niu, S.; Song, C.; Zhang, Z.; Lu, G.; Qiao, C.; Hu, Y.; Yuen, K.Y.; Wang, Q.; Zhou, H.; Yan, J.; Qi, J. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell, 2020, 181(4), 894-904.e9.
[http://dx.doi.org/10.1016/j.cell.2020.03.045] [PMID: 32275855]

Krieger, E.; Vriend, G. YASARA View-molecular graphics for all devices-from smartphones to workstations. Bioinformatics, 2014, 30(20), 2981-2982.
[http://dx.doi.org/10.1093/bioinformatics/btu426] [PMID: 24996895]

Schrödinger Release 2020-4: Desmond Molecular Dynamics System,D. E. Shaw Research;; Maestro-Desmond Interoperability tools: New York, NY, 2020.

Mark, P.; Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys. Chem. A, 2001, 105(43), 9954-9960.
[http://dx.doi.org/10.1021/jp003020w]

Jorgensen, W.L.; Maxwell, D.S.; Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc., 1996, 118(45), 11225-11236.
[http://dx.doi.org/10.1021/ja9621760]

Berne, M.T. J. Phys. Chem., 1993, 97(51), 13429-13434.
[http://dx.doi.org/10.1021/j100153a002]

Cheng, A.; Merz, K.M. Application of the Nosé-Hoover chain algorithm to the study of protein dynamics. J. Phys. Chem., 1996, 100(5), 1927-1937.
[http://dx.doi.org/10.1021/jp951968y]

Kumar, B.K.; Faheem.; Sekhar, K.V.G.C.; Ojha, R.; Prajapati, V.K.; Pai, A.; Murugesan, S. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. J. Biomol. Struct. Dyn., 2020, 0(0), 1-24.
[PMID: 32469279]

Karan Kumar, B.; Faheem; Balana Fouce, R.; Melcon-Fernandez, E.; Perez-Pertejo Yolanda, Y.; Reguera, R.M.; Adinarayana, N.; Chandra Sekhar, K.V.G.; Vanaparthi, S.; Murugesan, S. Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents. J. Biomol. Struct. Dyn., 2021, 0(0), 1-16.
[http://dx.doi.org/10.1080/07391102.2021.1973564] [PMID: 34488559]

Jayaram, B.; Singh, T.; Mukherjee, G.; Mathur, A.; Shekhar, S.; Shekhar, V. Sanjeevini: a freely accessible web-server for target directed lead molecule discovery. BMC Bioinformatics, 2012, 13(Suppl. 17), S7.
[http://dx.doi.org/10.1186/1471-2105-13-S17-S7]